However, there was an obvious association between RFC1 G80A polymorphism and ALL risk under the heterozygote model (OR = 1.368, 95 % CI 1.056-1.772, P=0.018) (Figure 2b). This evidence concerns the gene RFC1 and acute lymphoblastic leukemia.